Integrated analysis of microRNAs, transcription factors and target genes expression discloses a specific molecular architecture of hyperdiploid multiple myeloma.
Loading...
Embargo End Date
ICR Authors
Authors
Di Martino, MT
Guzzi, PH
Caracciolo, D
Agnelli, L
Neri, A
Walker, BA
Morgan, GJ
Cannataro, M
Tassone, P
Tagliaferri, P
Guzzi, PH
Caracciolo, D
Agnelli, L
Neri, A
Walker, BA
Morgan, GJ
Cannataro, M
Tassone, P
Tagliaferri, P
Document Type
Journal Article
Date
2015-08-07
Date Accepted
2015-05-13
Abstract
Multiple Myeloma (MM) is a malignancy characterized by the hyperdiploid (HD-MM) and the non-hyperdiploid (nHD-MM) subtypes. To shed light within the molecular architecture of these subtypes, we used a novel integromics approach. By annotated MM patient mRNA/microRNA (miRNA) datasets, we investigated mRNAs and miRNAs profiles with relation to changes in transcriptional regulators expression. We found that HD-MM displays specific gene and miRNA expression profiles, involving the Signal Transducer and Activator of Transcription (STAT)3 pathway as well as the Transforming Growth Factor-beta (TGFβ) and the transcription regulator Nuclear Protein-1 (NUPR1). Our data define specific molecular features of HD-MM that may translate in the identification of novel relevant druggable targets.
Citation
Oncotarget, 2015, 6 (22), pp. 19132 - 19147
Source Title
Publisher
IMPACT JOURNALS LLC
ISSN
1949-2553
eISSN
1949-2553
Collections
Research Team
Molecular Haematology (including Cytogenetics Group and Cell Markers)